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Abstract
Background:Most children with epilepsy reside in resource-limited regions such as sub-Saharan Africa, where the majority
of studies have been conducted in rural areas with limited investigations. Medical records from children with epilepsy
seen at an urban hospital in Kenya were examined to provide a comprehensive description of epilepsy in children from
this hospital.
Methods:A retrospective observational study was conducted which involved reviewing medical records of 426 epilepsy
patients (260 males and 166 females) aged 0 - 18 years, seen in Nairobi, Kenya between February 2011 and December
2014.
Results:The most frequent age at presentation; documented in 29% was in infancy. Generalized seizures due to structural
brain abnormalities were the most common form of epilepsy (28%). Lennox-Gastaut Syndrome was the most common
electroclinical syndrome (7%). Focal seizures and focal seizures with loss of awareness were identified in 12% of the
population. There were no cases of childhood absence epilepsy in this group. Brain atrophy was the most common MRI
finding, occurring in a fifth of the population (20%), while cystic encephalomalacia occurred in 13%. Half (50%) of all
EEG recordings performed for this cohort were abnormal. Generalized seizures due to structural brain abnormalities and
Lennox-Gastaut Syndrome (LGS) were significant predictors of a treatment history of three or more AEDs. At the conclu-
sion of the review period, 16% of the patients had not visited the clinic for more than 12 months and were considered to
be lost to follow-up.
Conclusion:The highest frequency of epilepsy cases was documented in children less than one year of age. Generalized
seizures due to structural abnormalities and Lennox-Gastaut syndrome were the most common seizure type and syndrome.
Improvement of public awareness of different types of seizures in children may increase identification of children with
childhood absence epilepsy.
Kewords: epilepsy, children, electroclinical syndrome, Kenya, sub-saharan Africa
c© Samia P; licensee JICNA
Background1
The has identified epilepsy as presenting a significant bur-2
den as measured by Disability-adjusted life years (DALY)3
[1]. Epilepsy affects approximately 50-70 million peo-4
ple worldwide [1-3] and up to 80% of those affected re- 5
side in low and middle-income countries (LMIC), such as 6
those comprising the majority of Sub-Saharan Africa(SSA) 7
[2][3][4]. 8
According to studies in five SSA countries, the prevalence 9
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of active convulsive epilepsy ranges from 7.0 - 14.8 per 100010
people [5]. Consistent with the global trend, the highest11
incidence of epilepsy in Africa occurs in the paediatric pop-12
ulation [6]. The high prevalence of paediatric epilepsy in13
SSA is attributed to preventable risk factors including: poor14
perinatal care, endemic infectious diseases and head injury15
[6][7]. Factors contributing to the high epilepsy treatment16
gap in SSA include limitations in accessing adequate diag-17
nostic and treatment services as well as negative cultural18
and social beliefs regarding epilepsy [3][4][6][8].19
Following the 2010 proposal, Revised terminology and20
concepts for organization of seizures and epilepsies pro-21
duced by the International League Against Epilepsy(ILAE)22
Commission on Classification and Terminology [9], Schef-23
fer et al. proposed an organization of epilepsy diagno-24
sis based on electroclinical syndrome and aetiology [10].25
An electroclinical syndrome is a presentation of epilepsy26
that demonstrates specific outcomes, clinical and electroen-27
cephalogram(EEG) characteristics [9][10]. In resource-28
limited settings, various challenges present limitations for29
delineating epilepsy according to electroclinical syndrome30
and aetiology. Recent population and hospital-based stud-31
ies conducted in Africa providing descriptions of epilepsy32
in children based on these electro-clinical syndromes or33
syndrome-associated outcomes are sparse to non-existent34
[6][10][11][12]. This paper describes the static and dy-35
namic demographic characteristics of the patient population36
and seizure onset; electroclinical syndromes and seizure37
types; structural and electrophysiological brain abnormal-38
ities; types and number of anti-seizure medications(ASM)39
administered; co-morbidities and patient attrition rates.40
Methods41
Paediatric neurologists and local medical personnel practic-42
ing in low-resource settings face multiple challenges. Access43
to neuroimaging and specialised neurophysiological testing,44
such as electroencephalography(EEG), is typically concen-45
trated in single centres, usually located in larger cities.46
This was a retrospective observational study based on a47
review of the medical records of children and adolescents48
(aged 0 - 18 years) with epilepsy who were seen at Aga49
Khan University Hospital, Nairobi, Kenya between 2011 and50
2014. The hospital is an urban academic institution which51
functions as a primary referral hospital for clients in the52
vicinity and also acts as a tertiary university hospital with53
facilities for EEG and neuroimaging. The hospital further54
provides supportive funding for patients without capacity to55
pay for such services. Approximately 10% of patients seen at56
the paediatric neurology clinic were sponsored by the hos-57
pital and another 10% had their medical costs supported by58
the National Hospital Insurance Fund (NHIF), Kenya’s na-59
tional health insurance scheme. It is estimated that 65% of60
patients seen at this facility are referrals from outside of the61
Aga Khan University hospital network of facilities.62
The patient medical records examined consisted of phys-63
ical files and as well as information stored on the hospital’s 64
electronic databases. Physical files of patients seen at the 65
hospital during this period indicating a history of seizures 66
or diagnosis of epilepsy were obtained from the medical 67
records department using ICD-10 (International Classifica- 68
tion of Diseases, Tenth Revision) codes utilized at the time of 69
archiving. From these records, all patients diagnosed with 70
epilepsy, according to the ILAE 2014 definition of epilepsy, 71
were selected for inclusion in the study [13]. According to 72
the ILAE, epilepsy is defined as two or more unprovoked 73
seizures occurring at least 24 hours apart, or one unpro- 74
voked seizure with a probability of recurrence determined 75
to be greater than 60% [13]. Based on this definition, the 76
following patients were excluded from the study: patients 77
presenting with typical simple febrile seizures only; patients 78
with a single seizure episode without an epilepsy syndrome 79
diagnosis or identifiable structural brain abnormality; those 80
with a single provoked seizure in the context of fever or 81
hypocalcemia, for example; as well as those with episodes of 82
syncope only; or non-epileptic, psychogenic seizures solely. 83
Evaluation for co-morbidities such as attention deficity 84
hyperactivity disorder(ADHD)and autism spectrum disor- 85
der(ASD) were made by the paediatric neurologist who 86
assumed care for the children. Screening for these co- 87
morbidities was done using National Institute for Children’s 88
Health Quality (NICHQ), Vanderbilt Assessment Scales for 89
ADHD and the Diagnostic and Statistical Manual of Men- 90
tal Disorder, Fifth Edition (DSM V) for ASD. Where other 91
behavioural concerns were identified these children were 92
evaluated by a child psychiatrist. Results of these evalua- 93
tions were included in patient records. During regular clinic 94
visits data on patient developmental progress was also in- 95
cluded in the medical records. 96
Data on patient sex; age at seizure onset; electroclinical 97
diagnosis; structural brain abnormalities; number and type 98
of ASMs in treatment history; consistency of clinic follow- 99
up and co-morbidities were extracted as previously docu- 100
mented in the patient’s clinical notes. Further data was ob- 101
tained from clinical notes and technical reports describing 102
imaging and electrophysiological findings. The research as- 103
sistant who collected and analysed the data was trained and 104
supervised by the paediatric neurologist who assessed and 105
managed the patients. 106
Electroclinical syndrome diagnoses were determined ac- 107
cording to guidelines outlined in the Proposal for Revised 108
Classification of Epilepsies and Epileptic Syndromes, by the 109
Commission on Classification and Terminology of the ILAE 110
[9][10]. Epilepsy that could not be classified as an electro- 111
clinical syndrome was described according to seizure type 112
(i.e. generalized or focal) and cause (e.g. structural aetiol- 113
ogy) [9]. 114
Age at seizure onset was recorded in months and grouped 115
into one of four periods of onset: i) neonatal - where on- 116
set of seizures occurred within the first 28 days of life; ii) 117
infancy – where seizures commenced between 1 and 12 118
months of life; iii) childhood - where seizures began be- 119
tween 12 and 120 months (i.e. 1 - 10 years) of age; and iv) 120
2
DI
TE
D 
PR
OO
F
Li
ce
ns
ed
un
de
rt
he
te
rm
s
of
th
e
C
re
at
iv
e
C
om
m
on
s
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
-S
ha
re
A
lik
e
4.
0
In
te
rn
at
io
na
lL
ic
en
ce
.
D
ow
nl
oa
de
d
fro
m
ht
tp
s:
//j
ic
na
.o
rg
adolescence - where onset of seizures occurred between 120121
and 216 months of age (i.e. 10 years to 18 years). These122
groupings were based on WHO age classifications [14][15].123
The findings of all EEG reports were counter-checked by124
the paediatric neurologist. Brain magnetic resonance imag-125
ing(MRI) and head computed tomography(CT) reports gen-126
erated at both external hospitals and Aga Khan University127
Hospital were counter-checked by one neuroradiologist. Pa-128
tients who had not visited the clinic for twelve months or129
longer were defined as being lost to follow-up.130
This study was subjected to a full scientific and an expe-131
dited ethics review. The Aga Khan University Hospital Ethics132
Committee gave approval to conduct the study (reference133
number 2015/REC-27 (vl) dated 29th June 2015). Permis-134
sion to access records from Aga Khan University Medical135
Records Department was granted from 30th June 2015 to136
29th June 2016. As this was a retrospective review of med-137
ical records without direct patient contact, the Institutional138
Review Board(IRB) did not require patient consent to par-139
ticipate.140
In analysing the data, patients were grouped primarily by141
electroclinical syndrome [9][10]. In cases where an elec-142
troclinical diagnosis could not be applied, patients were143
categorised according to seizure type and aetiology where144
known [9].145
Variables including sex, age at seizure onset, use, re-146
sults of investigations into structural and electrophysiologi-147
cal brain abnormalities, consistency of clinic follow up and148
co-morbidities were documented for all patients in the study149
group and these were analysed using descriptive statistics150
and presented in frequency tables and distributions.151
Results152
A total of 1,106 children were seen at the paediatric neu-153
rology clinic between February 2011 and December 2014.154
Among these were 576 children with a history of seizures,155
of whom only 426 had a diagnosis of epilepsy and were in-156
cluded in the study as shown in Table 1.157
Sex and diagnosis frequency158
The male: female ratio was 1.6:1 (260 males and 166159
females), with males comprising 61% of the study popula-160
tion (Table 1). LGS was the most common electroclinical161
syndrome. Overall, of all the syndrome and seizure types,162
generalized seizures associated with structural brain abnor-163
malities was the most frequent form of epilepsy.164
Age at seizure onset165
Fifty-six percent of patients 56.6% (N = 241) developed166
seizures between 1 and 10 years of age while 29% (N =167
125) of patients developed seizures in infancy (between 1168
and 12 months of age.) Fewer patients, 7.5% (N = 32),169
presented with seizures for the first time between 10 and170
18 years. This data is shown in Table 2.171
Structural and electrophysiological brain abnormalities172
A total of 8.5% (N = 36) of patients had no investiga- 173
tion results available on file. The majority of the patients, 174
86.4% (N = 368) had a sleep EEG reported, while approx- 175
imately half of the study population, 48.8% (N = 208) had 176
a brain MRI scan with contrast. Reported findings from 177
the brain MRI scans are summarized in Table 3. Ten chil- 178
dren (4.8%) who had both brain MRI and head CT reports 179
had their findings included in the brain MRI group. Four 180
among these (0.9%) had both normal head CTs and brain 181
MRIs while three children (1.4%) had delayed myelination 182
on brain MRI. Two children (0.9%) had white matter hy- 183
perintensities and one child (0.4%) had polymicrogyria on 184
brain MRI. 185
Among those who did not have brain MRI, 19.2% (N = 186
106) of patients had CT scans, of which 53.4% (N = 57) 187
were abnormal. Brain atrophy and hydrocephalus were the 188
most common abnormalities identified in 45.6% (N = 26) 189
and (N = 10) 17.5% children respectively. A total of 47.2% 190
(N = 50) had normal head CT reports. In this cohort 26.2% 191
(N = 112) of children with epilepsy had no neuroimaging 192
records. 193
A total of 557 EEG recordings were performed for the 426 194
patients in the study. Among these, 5.9% of all the EEG 195
recordings (N = 33) demonstrated indeterminate findings, 196
while 43.1% (N = 240) of these were normal and 50.1% 197
(N = 284) were abnormal. Of the abnormal EEG record- 198
ings 56.7% (N = 161) showed generalized spike wave dis- 199
charges, 25.3% (N = 72) showed focal spike wave dis- 200
charges while 17.9% (N = 51) of abnormal EEG recordings 201
showed slowing activity. 202
Anti-seizure medication use 203
Of the total patient population, 89.4% (N = 381) had 204
been treated with one or more ASMs since onset of epilepsy 205
while 10.6% (N = 45) of patients had not been on MRI 206
treatment (Table 4). Among those on antiepileptic med- 207
ication, 42.7% (N = 176) of patients been treated with 208
one ASM , 24.2% (N = 100) with two ASMs, 17.4% (N 209
= 72) with three ASMs and 9.2% (N = 38) with four or 210
more ASMs serially. Table 4 summarizes types of ASMs that 211
were utilized in this population in order of frequency. As il- 212
lustrated above individual patients may have utilized more 213
than one medication. Valproic acid was the most commonly 214
used ASM with 69.4% usage amongst the study participants, 215
followed by Carbamazepine and Clonazepam with 24.2% 216
and 20.8% usage respectively. In contrast, Pregabalin and 217
Gabapentin were the least used (each having been utilized 218
by 0.3% of study participants). 219
Co-morbidities 220
Of the 426 children, 21.6% (N = 92) had psychiatric co- 221
morbidities: Among these 10.1% (N = 43) had ADHD; 8.2% 222
(N = 35) had ASD; 0.5% (N = 2) had mood disorders; 1.2% 223
(N = 5) had a psychosomatic illness; and 1.6% (N = 7) had 224
other behavioural concerns. Further, almost half of the pa- 225
tients with psychiatric co-morbidities 0.9% (N = 40) had 226
focal seizures with loss of awareness. Various neurodevel- 227
opmental co-morbidities were observed in this study popu- 228
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Table 1 Distribution of the Epilepsy diagnoses within the study sample, by sex
Diagnosis Total Male Female Proportion of Cohort %
N = 426 N = 260 N = 166
-100% -61% -39%
Epilepsy syndromes
Lennox-Gastaut syndrome(LGS) 29 18 11 6.8
Infantile spasms (West Syndrome) 22 12 10 5.2
Epilepsy with myoclonic astatic seizures(EMA) 5 4 1 1.2
Juvenile myoclonic epilepsy(JME) 5 1 4 1.2
Juvenile absence epilepsy(JAE) 3 2 1 0.7
Childhood epilepsy with centro-temporal spikes(CECTS) 2 2 0 0.5
Dravet syndrome 1 1 0 0.2
Seizure semiologies
Generalized Seizures with structural brain abnormalities 117 76 41 27.5
Generalized Epilepsies of unknown cause 99 60 39 23.2
Focal Seizures 52 28 24 12.2
Focal seizures with loss of awareness 40 26 14 9.4
Febrile seizures plus 44 24 20 10.3
Genetic Epilepsy with febrile seizures plus 7 6 1 1.6
N represents the number of study participants
Table 2 Distribution of age at seizure onset
Neonatal Infancy Childhood Adolescence
< 28 days 1-12 months 12-120 months 120-216 months
Diagnosis Total N % N % N % N %
Epilepsy syndromes
29 0 0 7 24.1 22 75.9 0 0
Infantile spasms (West Syndrome) 22 7 31.8 14 63.6 1 4.5 0 0
Epilepsy with myoclonic astatic seizures(EMA) 5 0 0 0 0 5 100 0 0
Juvenile myoclonic epilepsy(JME) 5 0 0 0 0 1 20 4 80
Juvenile absence epilepsy(JAE) 3 0 0 0 0 2 66.7 1 33.3
Childhood epilepsy with centro-temporal spikes(CECTS) 2 0 0 0 0 2 100 0 0
Dravet syndrome 1 0 0 1 100 0 0 0 0
Seizure semiologies
Generalized seizures with structural brain abnormalities 117 18 15.4 54 50.9 37 34.9 8 7.5
Generalized epilepsies of unknown cause 99 0 0 19 19.2 68 68.7 12 12.1
Focal Seizures 52 3 5.8 16 30.8 31 59.6 2 3.8
Focal seizures with loss of awareness 40 0 0 5 12.5 32 80 3 7.5
Febrile seizures plus 44 0 0 8 18.2 34 77.3 2 4.5
Genetic epilepsy with febrile seizures plus 7 0 0 1 14.3 6 85.7 0 0
Total 426 28 6.6 125 29.3 241 56.6 32 7.5
N represents the number of study participants
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lation. These included developmental delay in 27.9% (N =229
119) of patients; speech delay in 17.4% (N = 74); intellec-230
tual disability in 8.7% (N = 37); cerebral palsy in 15.3%231
(n = 65); and developmental milestone regression in 7.8%232
(N = 33) of patients. The greatest proportion of neurolog-233
ical co-morbidities was observed among patients with (N234
= 29), including developmental delay in 34.5% (N = 10)235
of patients, speech delay in 20.7% (N = 6), intellectual236
or learning disabilities in 27.6% (N = 8), and regression of237
milestones was in 24% (N = 7).238
Attrition rates239
At the conclusion of the review period, one patient had240
died and an additional 16.4% (N = 70) of study participants241
who had not visited the clinic for more than 12 months were242
considered to be lost to follow-up. In this group there were243
60% (N = 42) males and 40% (N = 28) females. Among244
these, 41.5% (N = 29) were aged less than 24 months at245
initial presentation to the clinic. The diagnosis of patients246
lost to follow up is summarized in Table 5.247
Discussion248
In Africa preventable factors such as perinatal insults dur-249
ing complications of delivery, maternal and infant infections250
and trauma contribute to the high prevalence of epilepsy251
[16][17][18][19][20][21][22]. Limited access to quality252
healthcare care facilities and services further negatively im-253
pact prevention and management of epilepsy on the con-254
tinent [19][23][24][25][26][27][28][29][30]. Epilepsy is255
associated with significant personal and social consequences256
including increased risk of injury, limited education, unem-257
ployment and social ostracism [31][32][33][34][35].258
Infants in their first year of life accounted for the highest259
incidence of epilepsy overall and the highest proportion of260
paediatric patients presenting with generalized seizures due261
to structural brain abnormalities. These two observations262
may be related to the significant proportion of infants who263
had birth injury and various other congenital brain malfor-264
mations. These findings are in keeping with a population265
study by Ellenberg et al showed that the highest incidence266
of non-febrile seizures occurred within the first year of life267
[36]. Targeted efforts to identify infants with epilepsy in the268
first year of life in this context would therefore be important269
in ameliorating morbidity associated with this condition.270
Generalized epilepsy has been found to be the most com-271
mon kind of epilepsy in many paediatric, and adult popu-272
lation studies [20][21][37]. This was found to be the case273
among patients in this cohort, a significant proportion of274
whom had generalized seizures due to structural abnormal-275
ities. This observation would be reflective of the fact that276
members of the cohort attended an urban medical facility277
where appropriate neuroimaging facilities were available.278
Data from various parts of rural Kenya regarding children279
with epilepsy indicate that generalized seizure are the most280
easily identifiable seizure presentations in the community281
[38][39]. Studies which reported higher prevalence of fo-282
cal onset seizures also reported a higher incidence of acute 283
symptomatic seizures in a malaria endemic area [40]. A 284
multi-site population study in the country may help eluci- 285
date the distribution of epilepsy seizure types better. 286
Generalized epilepsy of unknown cause was the second 287
most frequent type of epilepsy observed in this cohort. 288
Other studies in Africa have also demonstrated that the 289
cause of epilepsy can frequently be unknown [41][42][22]. 290
Inability to determine the cause of epilepsy is largely due to 291
financial and diagnostic limitations at the point of care [18]. 292
Further, genetic and metabolic testing is not available locally 293
and performance of these tests by overseas healthcare part- 294
ners is associated with significant financial costs and time 295
delays as has been our experience. This is particularly note- 296
worthy when considering that Kenya’s per capita GDP in 297
2016 was USD 1,410 [43], meaning that patients lacking 298
medical insurance cover would struggle to access requisite 299
tests such as the early infantile epileptic encephalopathy se- 300
quencing panel that costs USD 2000 on average. 301
Since generalized epilepsy of unknown cause was a fre- 302
quent observation amongst patients in this cohort, as in 303
other studies, and in light of potential benefits of deter- 304
mining the cause of epilepsy where possible, interventions 305
to improve the quality of and access to local diagnostic 306
facilities such as neuro-imaging, electroencephalography, 307
metabolic and genetic testing would be beneficial to the 308
management of epilepsy patients in sub-Saharan Africa. 309
Positive family history of febrile seizures in children who 310
presented with atypical febrile seizures allowing a diagnosis 311
of Genetic Epilepsy with febrile seizures plus was rarely de- 312
termined in this cohort. This could be due to low rates of di- 313
agnosis of atypical febrile seizures in this setting or cultural 314
reasons where families rarely discuss seizures in children 315
openly due to associated stigma. Cultural reasons may also 316
contribute to the predilection for more significantly male 317
children presenting for care at this centre. 318
In this cohort we identified no children with childhood 319
absence epilepsy(CAE) which being a common form of 320
epilepsy, was an unexpected finding [40][44]. This is most 321
likely due to under-recognition and lack of referral of such 322
cases to the neurology teams. It is possible CAE is managed 323
by paediatricians and being generally responsive to widely 324
available first line ASMs, referral in such cases would not be 325
required. 326
Critically, patients who are lost to follow-up are likely 327
to remain untreated. Long-standing, untreated epilepsy 328
has detrimental and enduring personal and social con- 329
sequences, including impaired intellectual performance 330
[31][32][33][34][35]. For these reasons, there is an ur- 331
gent need to determine the reasons for defaulting on clinic 332
follow-up [37]. Findings from these studies which may be 333
applicable to other similar hospital settings would enable 334
this institution to address these specific risk factors and po- 335
tentially reduce the number of children with epilepsy who 336
remain untreated. 337
Study limitations 338
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Table 3 Brain MRI findings in order of frequency
Brain findings Total Proportion of Cohort %
N = 208
Normal 55 26.4
Brain atrophy 41 19.7
Cystic encephalomalacia 26 12.5
Mesial temporal sclerosis 20 9.6
White matter hyper intensities 16 7.7
Hydrocephalus 11 5.3
Benign enlargement of the subdural space 8 3.8
Periventricular leukomalacia 6 2.9
Agenesis of corpus callosum 6 2.9
Delayed myelination 4 1.9
Tuberous sclerosis complex (sub-ependymal nodules, harmatomas, calcifications) 3 1.5
Hemimegalencephaly 3 1.5
Meningeal enhancement 3 1.5
Holoprosencephaly 2 0.9
Schizencephaly 2 0.9
Lissencephaly 1 0.5
Polymicrogyria 1 0.5
N represents the number of study participants
Table 4 utilized in epilepsy management
Medication N = 381 Proportion of cohort %
Valproic Acid 267 69.4
Phenobarbital 77 20
Clonazepam 80 20.8
Levetiracetam 46 11.9
Phenytoin 34 8.8
Vigabatrin 12 3.1
Carbamazepine 93 24.2
Lamotrigine 26 6.8
Topiramate 10 2.6
Pregabalin 1 0.3
Gabapentin 1 0.3
Clobazam 4 1
N represents the number of study participants
Findings presented here represent the context of an ur-339
ban hospital and would be beneficial to the populations in340
similar contexts but would not be directly generalizable to341
most of the sub-Saharan African population who lack ac-342
cess to care and facilities of this nature. Cognitive, motor343
and behavioural outcomes for the different syndromes or344
seizure groups were not studied as this information was not345
measured in a standardised fashion for all the patients in346
the study population. This was a retrospective study and347
as such, missing data as well as other factors could impact348
on the quality of data generated. Future prospective studies349
in this area should make provision for two reviews of each350
laboratory investigation and plan to address inter-rater vari-351
ance.352
Conclusions 353
The study identified that males comprised the majority of 354
paediatric epilepsy patients seen at this paediatric neurol- 355
ogy service while LGS was the most common electroclini- 356
cal syndrome. Generalized seizures associated with struc- 357
tural brain abnormalities were the most frequent form of 358
epilepsy overall. Half of all EEGs performed displayed ab- 359
normalities including generalized spike wave discharges, fo- 360
cal spike wave discharges and slow background activity in 361
decreasing occurrence respectively. Majority of patients had 362
been treated with one ASM only, with valproic acid being 363
most common utilized ASM. Psychiatric co-morbidities were 364
more commonly identified in children with focal seizures 365
while and those with Lennox Gastaut syndrome were more 366
likely to present with developmental delay. The findings 367
from this study hold significant relevance for the improved 368
diagnosis and management of epilepsy among paediatric 369
patients in urban SSA, including need for: greater preven- 370
tive and diagnostic care predominantly targeting children 371
in the 1 to 10 year age group; increased efforts to address 372
patient attrition rates; and improvement of practitioner and 373
public awareness of common forms of epilepsy to facilitate 374
early detection and appropriate referral and management. 375
This paper’s contribution to existing research concerns its 376
potential to address a dearth of recent studies conducted 377
in sub-Saharan Africa describing electro-clinical syndromes 378
or syndrome-associated outcomes among children in the re- 379
gion. Prospective studies may seek to explore precise rela- 380
tionships between specific syndromes and variable such as 381
psychiatric and neuro-developmental co-morbidities and re- 382
sponses to anti-epileptic drugs. 383
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Table 5 Diagnosis of patients lost to follow up
Diagnosis N = 70 Proportion of cohort %
Focal seizures with loss of awareness 6 8.3
5 7
Generalized epilepsies of unknown cause 39 55.7
Focal seizures 4 5.7
Epileptic spasms (West syndrome) 2 2.8
Generalized Seizures with structural brain abnormalities 4 5.6
2 2.8
1 1.4
N represents the number of study participants
Abbreviations384
ADHD Attention deficity hyperactivity disorder385
ASD Autism spectrum disorder386
ASM Anti-seizure medication387
CAE Childhood absence epilepsy388
CECTS Childhood epilepsy with centro-temporal spikes389
DALY Disability-adjusted life years390
EEG Electroencephalogram391
EMA Epilepsy with myoclonic astatis seizures392
ILAE International League Against Epilepsy393
JAE Juvenile absence epilepsy394
JME Juvenile myoclonic epilepsy395
LGS Lennox-Gastaut syndrome396
LMIC Low and Middle Income Countries397
MRI Magnetic resonance imaging398
SSA Sub-Saharan Africa399
WHO World Health Organization400
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